Merck's biosimilar to AbbVie's Humira wins FDA approval
July 23, 2019 at 17:41 PM EDT
The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday.